Hernández-Gómez Cristhian, Hercilla Luis, Mendo Fernando, Pérez-Lazo Giancarlo, Contreras Elias, Ramírez Eresvita, Flores Wilfredo, Julca Ángela, Chuquiray Nancy, Arenas Berenice, Abarca Susan, Viñas Mario, Linares Elba, Villegas María Virginia, Illescas Luis Ricardo
Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque, Bogotá, D.C., Colombia.
Hospital Nacional Alberto Sabogal Sologuren, Lima, Perú.
Rev Chilena Infectol. 2019 Oct;36(5):565-575. doi: 10.4067/S0716-10182019000500565.
Antimicrobial resistance (AMR) is a global threat to public health. Antibiotic stewardship programs (AMSP) promote the proper use of antimicrobials, improve clinical and economic outcomes, and helps containing the AMR.
To evaluate the diagnostic phase of the AMS programs and early implementation of AMS at three high complexity hospitals that belong to the social security system in Peru.
A quasi-experimental multicenter study was implemented. The construction of the AMSP, microbiological baselines, antimicrobial consumption and consensus on AMS activities were evaluated at the diagnosis and early implementation periods of the AMSP.
Following implementation, hospitals doubled their score of resources and processes available for the AMS program from 6.75 to 13.75. The prevalence of extended spectrum beta-lactamase producing enterobacteria was 50-60% while Pseudomonas aeruginosa averaged 69% resistance to carbapenems. The defined daily dose (DDD) of ceftriaxone was 13.63, vancomycin 7.35 and meropenem 6.73 in average. Hospitals A and C decreased the use of antimicrobials (30-50%).
The implementation of the AMSP in the three hospitals was achieved through diverse strategies designed by multidisciplinary teams, which in addition to its articulation, reduce the consumption of broad spectrum antimicrobials at an early stage.
抗菌药物耐药性(AMR)是对公共卫生的全球性威胁。抗生素管理计划(AMSP)促进抗菌药物的合理使用,改善临床和经济结果,并有助于控制AMR。
评估秘鲁社会保障系统所属的三家高复杂性医院的AMSP诊断阶段及AMSP的早期实施情况。
开展了一项准实验性多中心研究。在AMSP的诊断和早期实施阶段,对AMSP的构建、微生物学基线、抗菌药物消费以及AM活动的共识进行了评估。
实施后,医院用于AMSP的资源和流程得分从6.75提高到13.75,翻了一番。产超广谱β-内酰胺酶肠杆菌的患病率为50%-60%,而铜绿假单胞菌对碳青霉烯类药物的平均耐药率为69%。头孢曲松的限定日剂量(DDD)平均为13.63,万古霉素为7.35,美罗培南为6.73。A医院和C医院减少了抗菌药物的使用(30%-50%)。
这三家医院通过多学科团队设计的多种策略实施了AMSP,这些策略除了相互配合外,还在早期阶段减少了广谱抗菌药物的使用。